These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 209148)

  • 1. The pathogenesis of myasthenia gravis.
    Heilbronn E; Stålberg E
    J Neurochem; 1978 Jul; 31(1):5-11. PubMed ID: 209148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 3. Presynaptic function modified by acetylcholine-receptor interaction in experimental autoimmune myasthenia gravis.
    Takamori M; Sakato S; Okumura S
    J Neurol Sci; 1984; 66(2-3):245-53. PubMed ID: 6099402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis: further electrophysiological and ultrastructural analysis of transmission failure in the mouse passive transfer model.
    Toyka KV; Birnberger KL; Anzil AP; Schlegel C; Besinger U; Struppler A
    J Neurol Neurosurg Psychiatry; 1978 Aug; 41(8):746-53. PubMed ID: 210263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.
    Lindstrom J
    Annu Rev Immunol; 1985; 3():109-31. PubMed ID: 2998417
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of receptor function as a pathogenetic principle in myasthenia gravis].
    Toyka KV
    Internist (Berl); 1988 Jun; 29(6):414-9. PubMed ID: 3042682
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathologic events at the endplate in myasthenia gravis.
    Ashizawa T; Appel SH
    Springer Semin Immunopathol; 1985; 8(3):177-96. PubMed ID: 2413561
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental autoimmune myasthenia gravis and cholinergic ionophore: an electrophysiologic study.
    Takamori M; Mori M; Kasai M
    Neurology; 1979 Jul; 29(7):945-50. PubMed ID: 572943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological studies of thymectomized and nonthymectomized acetylcholine receptor-immunized animal models of myasthenia gravis.
    Niemi WD; Nastuk WL; Chang HW; Penn AS; Rosenberry TL
    Exp Neurol; 1979 Jan; 63(1):1-27. PubMed ID: 223859
    [No Abstract]   [Full Text] [Related]  

  • 10. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.
    Simpson JA
    Muscle Nerve; 1978; 1(2):151-6. PubMed ID: 220530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis (first of two parts).
    Drachman DB
    N Engl J Med; 1978 Jan; 298(3):136-42. PubMed ID: 201840
    [No Abstract]   [Full Text] [Related]  

  • 12. An electrophysiological and morphological study of the neuromuscular junction in patients with myasthenia gravis.
    Albuquerque EX; Rash JE; Mayer RF; Satterfield JR
    Exp Neurol; 1976 Jun; 51(3):536-63. PubMed ID: 179836
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis animal model: quantitative analysis of the efficiency of pre- and postjunctional regions of intercostal muscles in rabbits immunized with Torpedo acetylcholine receptor.
    Albuquerque EX; Eldefrawi AT; Oliveira AC; Copio DS; Eldefrawi ME
    Exp Neurol; 1979 Oct; 66(1):109-22. PubMed ID: 225189
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
    Kelly JJ; Lambert EH; Lennon VA
    Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental myasthenia: lack of correlation between the autoantibody titer and the reduction of acetylcholine-controlled ionic channels measured at functioning endplates.
    Hohlfeld R; Sterz R; Kalies I; Wekerle H; Peper K
    Muscle Nerve; 1983 Feb; 6(2):160-3. PubMed ID: 6304508
    [No Abstract]   [Full Text] [Related]  

  • 16. Acetylcholine-induced channels and transmitter release at human endplates.
    Cull-Candy SG; Miledi R; Trautmann A
    Nature; 1978 Jan; 271(5640):74-5. PubMed ID: 625328
    [No Abstract]   [Full Text] [Related]  

  • 17. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome.
    Lindstrom JM; Lambert EH
    Neurology; 1978 Feb; 28(2):130-8. PubMed ID: 202890
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduction of miniature end-plate potential amplitude in extraocular and limb muscles in an animal model of myasthenia gravis.
    Zahm DS; Kim YI; Liu HH; Johns TR
    Exp Neurol; 1983 Apr; 80(1):258-62. PubMed ID: 6832272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
    Engel AG
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.